The Swedish private-equity firm is planning to sell its stake in a Singapore-based healthcare provider for about $600 million, according to people familiar with the situation.
The Swedish private-equity firm is planning to sell its stake in a Singapore-based healthcare provider for about $600 million, according to people familiar with the situation.